Home > Insider Trading > Filing (0001209191-18-054992)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1300699	Athenex Inc.	ATNX	Pharmaceutical Preparations (2834)	431985966

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1314254	Jinn Wu	C/O Athenex, Inc. 1001 Main Street, Suite 600 Buffalo NY 14203		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-10-15	12,500	$13.47	311,208	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy)	$4.55	2013-01-02	2023-01-02	90,000	90,000	Direct
Common Stock	Stock Option (Right to Buy)	$4.55	2014-02-12	2024-02-12	10,000	10,000	Direct
Common Stock	Stock Option (Right to Buy)	$5.50	2015-02-05	2025-02-05	54,000	54,000	Direct
Common Stock	Stock Option (Right to Buy)	$5.50	2017-03-20	2025-03-20	96,000	96,000	Direct
Common Stock	Stock Option (Right to Buy)	$11.00		2027-06-13	28,500	28,500	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2023-01-02	90,000	90,000	Direct
2024-02-12	10,000	10,000	Direct
2025-02-05	54,000	54,000	Direct
2025-03-20	96,000	96,000	Direct
2027-06-13	28,500	28,500	Direct

Footnotes

This transaction was executed in multiple trades at prices ranging from $13.34 to $13.51. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
The option vests in four equal annual installments beginning on June 13, 2018.